Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 32.6B | 26.3B | 27.9B | 26.6B |
Cost of revenue | 17.3B | 17.0B | 14.1B | 13.1B |
Gross profit | 15.3B | 9.3B | 13.8B | 13.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.0B | 8.4B | 2.9B | 2.9B |
Other operating expenses | 3.6B | -5.3B | 3.5B | 3.3B |
Operating income | 6.1B | 4.1B | 4.9B | 4.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 100M | -60M | 130M | 110M |
Other income expense | — | — | — | — |
Pretax income | 6.6B | 4.4B | 5.2B | 5.5B |
Tax provision | 1.4B | 960M | 1.1B | 1.2B |
Net income | 5.1B | 3.5B | 4.1B | 4.3B |
Basic EPS | 3.9 | — | 3.1 | 3.3 |
Diluted EPS | 3.9 | — | 3.1 | 3.3 |
Basic average shares | 1.3B | — | 1.3B | 1.3B |
Diluted average shares | 1.3B | — | 1.3B | 1.3B |
EBITDA | 7.1B | 4.9B | 5.8B | 6.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -90M | -20M | -70M | -100M |
Preferred stock dividends | 0 | 0 | 0 | 0 |